Deep Learning‐Enhanced Chemiluminescence Vertical Flow Assay for High‐Sensitivity Cardiac Troponin I Testing
Small · 2025
DOI: 10.1002/smll.202411585 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2025. Verfasst von Gyeo-Re Han und 13 weiteren Autor:innen. Beteiligte Einrichtung: Electrical & Computer Engineering Department, University of California, Los Angeles, CA, 90095, USA. Hauptthemen laut MEDLINE: Troponin I, Deep Learning, Luminescent Measurements, Myocardium. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Education, National Science Foundation.
Abstract (Originalsprache)
Democratizing biomarker testing at the point‐of‐care requires innovations that match laboratory‐grade sensitivity and precision in an accessible format. Here, high‐sensitivity detection of cardiac troponin I (cTnI) is demonstrated through innovations in chemiluminescence‐based sensing, imaging, and deep learning‐driven analysis. This chemiluminescence vertical flow assay (CL‐VFA) enables rapid, low‐cost, and precise quantification of cTnI, a key cardiac protein for assessing heart muscle damage and myocardial infarction. The CL‐VFA integrates a user‐friendly chemiluminescent paper‐based sensor, a polymerized enzyme‐based conjugate, a portable high‐performance CL reader, and a neural network‐based cTnI concentration inference algorithm. The CL‐VFA measures cTnI over a broad dynamic range covering six orders of magnitude and operates with 50 µL of serum per test, delivering results in 25 min. This system achieves a detection limit of 0.16 pg mL −1 with an average coefficient of variation under 15%, surpassing traditional benchtop analyzers in sensitivity by an order of magnitude. In blinded validation, the computational CL‐VFA accurately measures cTnI concentrations in patient samples, demonstrating a robust correlation against a clinical‐grade FDA‐cleared analyzer. These results highlight the potential of CL‐VFA as a robust diagnostic tool for accessible, rapid cardiac biomarker testing that meets the needs of diverse healthcare settings, from emergency care to underserved regions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Electrical & Computer Engineering Department, University of California, Los Angeles, CA, 90095, USA.
- Bioengineering Department, University of California, Los Angeles, CA, 90095, USA.
- Department of Psychology, University of California, Los Angeles, CA, 90095, USA.
- Chemical and Biomolecular Engineering Department, University of California, Los Angeles, CA, 90095, USA.
- Mechanical and Aerospace Engineering Department, University of California, Los Angeles, CA, 90095, USA.
- Biomedical Engineering Department, University of California, Davis, CA, 95616, USA.
ORCID-Profile: Gyeo-Re Han, Omai B Garner, Dino Di Carlo, Aydogan Ozcan
Förderung
- Ministry of Education
- National Science Foundation
Zitieren
APA
Han, G. R., Goncharov, A., Eryilmaz, M., Ye, S., Joung, H. A., Ghosh, R., Ngo, E., Tomoeda, A., Lee, Y., Ngo, K., Melton, E., Garner, O. B., Di Carlo, D., & Ozcan, A. (2025). Deep Learning‐Enhanced Chemiluminescence Vertical Flow Assay for High‐Sensitivity Cardiac Troponin I Testing. Small. https://doi.org/10.1002/smll.202411585
Vancouver
Han GR, Goncharov A, Eryilmaz M, Ye S, Joung HA, Ghosh R, et al. Deep Learning‐Enhanced Chemiluminescence Vertical Flow Assay for High‐Sensitivity Cardiac Troponin I Testing. Small. 2025. doi:10.1002/smll.202411585
BibTeX
@article{Han2025,
author = {Han, Gyeo-Re and Goncharov, Artem and Eryilmaz, Merve and Ye, Shun and Joung, Hyou-Arm and Ghosh, Rajesh and Ngo, Emily and Tomoeda, Aoi and Lee, Yena and Ngo, Kevin and Melton, Elizabeth and Garner, Omai B and Di Carlo, Dino and Ozcan, Aydogan},
title = {Deep Learning‐Enhanced Chemiluminescence Vertical Flow Assay for High‐Sensitivity Cardiac Troponin I Testing},
journal = {Small},
year = {2025},
doi = {10.1002/smll.202411585}
}
EUVIMED